Bright Minds Biosciences Inc.
DRUG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001827401
No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Bright Minds Biosciences Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +4 vs. Q2 2022
- Shares held
- 412.9K
- −74.8K (−15.3%) vs. Q2 2022
- Total value
- $509.0K
- +$110.0K (+27.6%) vs. Q2 2022
- New holders
- 6
- 2 more added
- Sold out
- 2
- 2 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DRUG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 99 | $653.8M |
| Q1 2026 | 94 | $670.3M |
| Q4 2025 | 74 | $514.9M |
| Q3 2025 | 64 | $366.1M |
| Q2 2025 | 47 | $137.0M |
| Q1 2025 | 34 | $188.4M |
| Q4 2024 | 31 | $176.4M |
| Q3 2024 | 6 | $229.8K |
| Q2 2024 | 6 | $208.2K |
| Q1 2024 | 7 | $255.6K |
| Q4 2023 | 8 | $329.8K |
| Q3 2023 | 6 | $309.2K |
| Q2 2023 | 8 | $326.3K |
| Q1 2023 | 9 | $256.7K |
| Q4 2022 | 9 | $309.6K |
| Q3 2022 | 14 | $509.0K |
| Q2 2022 | 10 | $399.0K |
| Q1 2022 | 11 | $628.0K |
| Q4 2021 | 9 | $2.93M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Bright Minds Biosciences Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 285,278 | $351.0K | 0.09% | −4,298−1.5% | Reduced |
| Quattro Financial Advisors LLC | 21,150 | $26.0K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 19,327 | $24.0K | 0.00% | −5,373−21.8% | Reduced |
| UBS Group AG | 14,834 | $18.0K | 0.00% | +7,557+103.8% | Added |
| Checchi Capital Advisers, LLC | 14,138 | $17.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 11,801 | $15.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 11,069 | $14.0K | 0.00% | +11,069 | New |
| First Republic Investment Management, Inc. | 11,329 | $14.0K | 0.00% | +11,329 | New |
| Bank of America Corp | 10,655 | $13.0K | 0.00% | +10,655 | New |
| Two Sigma Securities, LLC | 10,204 | $13.0K | 0.00% | +10,204 | New |
| Royal Bank of Canada | 1,595 | $2.00K | 0.00% | +16+1.0% | Added |
| Aspire Private Capital, LLC | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 629 | $1.00K | 0.00% | +629 | New |
| Advisor Group Holdings, Inc. | 400 | $0 | 0.00% | +400 | New |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −105,958−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −11,040−100.0% | Sold out |